CN101352504B - Bedsore plaster and method for producing the same - Google Patents
Bedsore plaster and method for producing the same Download PDFInfo
- Publication number
- CN101352504B CN101352504B CN2008101413345A CN200810141334A CN101352504B CN 101352504 B CN101352504 B CN 101352504B CN 2008101413345 A CN2008101413345 A CN 2008101413345A CN 200810141334 A CN200810141334 A CN 200810141334A CN 101352504 B CN101352504 B CN 101352504B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- bedsore
- temperature
- filtrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention discloses a bedsore plaster which is prepared from the following bulk drugs in part by weight: 5 to 15 parts of dried rehmannia root, 5 to 15 parts of achyranthes root, 10 to 20 parts of angelica, 5 to 20 parts of corydalis tuber, 5 to 15 parts of frankincense, 2 to 10 parts of safflower, 5 to 20 parts of scutellaria root, 5 to 20 parts of corktree bark, 5 to 20 parts of atractylodes rhizome, 1 to 5 parts of dragons blood, 0.5 to 5 parts of borneol, 1 to 15 parts of notoginseng, 0.1 to 2 parts of Qingfen, 100 to 150 parts of beeswax, and 800 to 1500 parts of sesame oil. The production method of the bedsore plaster comprises the steps: materials are selected, purified and processed, and the sesame oil is heated for 20 to 30 minutes; the dried rehmannia root, the achyranthes root, the angelica, the corydalis tuber, the frankincense, the safflower, the scutellaria root, the corktree bark and the atractylodes rhizome are put into a container and heated for 20 to 30 minutes, purified and filtered to obtain filtrate; the beeswax and the notoginseng powder are added into the filtrate when the filtrate is cooled down to a temperature ranging from 120 to 180 DEG C; the borneol, the dragons blood and Qingfen are added to the filtrate when the temperature of the filtrate drops to 70 to 90 DEG C; after materials are dissolved, the solution is hermetically sealed, cooled and caned to obtain the bedsore plaster of the invention. The bedsore paste has the advantage of good curative effect, the effective rate is up to 96 percent and the curative ratio is up to 98 percent.
Description
Technical field:
The present invention relates to a kind of ointment, particularly relate to a kind of band bed sore ointment and production method thereof for the treatment of various decubital ulcers, belong to drug world.
Background technology:
Decubital ulcer (having another name called pressure ulcer or bed-sore) is that the skin decubital ulcer is the problem of a universality in rehabilitation, nursing owing to the result in latter stage of nutrition blood confession with body tissue generation circulatory disorders.The reason that decubital ulcer takes place: 1. local long-term pressurized, the prolonged position that do not change, cause disturbance of blood circulation and that histotrophic nutrition takes place is bad, be common in and incorrectly partly sit clinostatism or seat, paralysis, stupor, get old and weak, become thin, can not own mobile position person after edema and the operation; 2. skin often is subjected to the stimulation of physical factors such as humidity and friction, chip is arranged, draw, use depainting closet etc. when standing up as a large amount of perspiration, gatism, secretions, vomitus, clothes out-of-flatness, sheet fold, can cause keratodermatitis impaired, resistance reduces; 3. when using plaster bandage, clamping plate, liner is improper, and the degree of tightness discomfort causes the local organization disturbance of blood circulation; 4. pantatrophia or local organization blood supply insufficiency and diseases prevention ability reduce, and all easily cause the generation of decubital ulcer, as patients such as long-term heating and cachexia.An easily position of decubital ulcer: pilosity is born in no muscle parcel or Musclar layer is thin, lack the fatty tissue protection bone knuckle place of frequent pressurized again.As the outside, medial and lateral malleolus in the solemnly prominent place of occipitalia, auricle, omoplate, ancon, vertebral body, hip, sacrococcygeal region, the knee joint, heel portion etc. are located.Also can betide anterior superior iliac spine, costal margin protuberance, knee etc. when prostrate and locate, it is relevant with patient's clinostatism easily to send out the position.
Decubital ulcer is brought very painful torment to the patient, have is to make the matter worse, decubital ulcer is also comparatively difficult in treatment, even in the bad place of some sanitary conditions, also can cause infested, make us forbidding, the patient who dies from the decubital ulcer disease is a lot, septicemia, tetanus and the cardiopulmonary infection etc. that cause as decubital ulcer.The traditional method of treatment decubital ulcer is to change dressings in infrared ray radiation or part, but the effect of its clinical practice is bad, and expensive price, treatment time is longer, patient is agonizing, treat also undesirable, therefore, decubital ulcer is perplexing clinician and patient household for a long time always, and the medicine of expecting the treatment decubital ulcer that a kind of clinical effectiveness is good comes out and benefits people.
Summary of the invention:
Technical problem to be solved by this invention is: overcome the deficiencies in the prior art, a kind of fill a prescription reasonable, that clinical effectiveness is good band bed sore ointment and production method thereof are provided.
The technical scheme that the present invention is taked for the technical solution problem is:
A kind of band bed sore ointment forms by the following bulk drugs that with the weight portion is unit is refining: 5～15 parts in the Radix Rehmanniae, 5～15 parts of Radix Achyranthis Bidentataes, 10～20 parts of Radix Angelicae Sinensis, 5～20 parts of Rhizoma Corydalis, 5～15 parts of Olibanums, 2～10 parts on Flos Carthami, 5～20 parts of Radix Scutellariaes, 5～20 parts of Cortex Phellodendris, 5～20 parts of Rhizoma Atractylodis, 1～5 part of Sanguis Draxonis, 0.5～5 part of Borneolum Syntheticum, 1～15 part of Radix Notoginseng, 0.1～2 part of Calomelas, 100～150 parts in Cera Flava, 800～1500 parts in Oleum Sesami.
Described band bed sore ointment is formed by the following natural material YAOJING system that with the weight portion is unit: 10 parts in the Radix Rehmanniae, 10 parts of Radix Achyranthis Bidentataes, 12 parts of Radix Angelicae Sinensis, 9 parts of Rhizoma Corydalis, 9 parts of Olibanums, 5 parts on Flos Carthami, 9 parts of Radix Scutellariaes, 9 parts of Cortex Phellodendris, 9 parts of Rhizoma Atractylodis, 2 parts of Sanguis Draxonises, 1 part of Borneolum Syntheticum, 5 parts of Radix Notoginseng, 0.5 part of Calomelas, 120 parts in Cera Flava, 1000 parts in Oleum Sesami.
The production method of band bed sore ointment recited above, its concrete steps are as follows:
A. select materials: select first-class medicine according to the crude drug weight proportion;
B. purify: according to the conventional medicine processing method, various raw materials are cleaned, purify, concoct, standby then;
C. the Oleum Sesami of described weight portion is put into container, under 210～240 ℃ temperature conditions, heated 20～30 minutes;
D. the Radix Rehmanniae, Radix Achyranthis Bidentatae, Radix Angelicae Sinensis, Rhizoma Corydalis, Olibanum, Flos Carthami, Radix Scutellariae, Cortex Phellodendri, Rhizoma Atractylodis are added in the container, heating 20～30 minutes is continued in the back that stirs, and temperature is controlled at 210～240 ℃, roguing, filters, leaves standstill;
E. treat to add when the filtrate temperature is reduced to 120～180 ℃ Cera Flava and Radix Notoginseng powder, the roguing of mixing and stirring after-filtration;
Add Borneolum Syntheticum, Sanguis Draxonis and Calomelas when treating F. that temperature of liquid is reduced to 70～90 ℃, mixing and stirring is after dissolving, airtight, leave standstill, cool off;
G. treat that temperature drops to fill behind the room temperature.
The present invention all adopts pure Chinese medicine ingredients, under the guidance of wet treatment principle, adopts the different methods of changing dressings to reach therapeutic purposes.Medicine of the present invention is to be foundation with 2000 " Pharmacopoea Chinensis ", therefrom filter out have blood circulation promoting and blood stasis dispelling, refining the forming of medicine of heat-clearing and toxic substances removing, YIN nourishing and the production of body fluid promoting, blood circulation promoting regulates qi pain relieving, granulation promoting, prescription is rationally, processing method is simple, easy to use, economical, laborsaving, therapeutic effect is remarkable.
Band bed sore ointment of the present invention is the special medicament of all types of decubital ulcers of treatment, it be according to theory of Chinese medical science for the basis, determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs is principle, in line with the attitude of the Scientific Outlook on Development, modern medicine and the advanced technology of combining closely is refining to form.This invention is to begin development in 74 years, it is clinical to drop into decubital ulcer in 76 years, go through three more than ten years 1220 example the clinical use of all kinds of patients with bedsore in various degree, nontoxic, harmless, have no side effect, effective percentage 96%, cure rate 98%, no pain, infection in whole therapeutic process, removing the necrotic tissue and promoting granulation, wound healing is rapid.
Scientific formulation uniqueness of the present invention, operation is simple, easy to use, is applicable to various medical institutions, family ward, and family numbers of patients oneself can be operated treatment, is the good medicine that welcome by the masses.This medicine not only has unique curative effect to decubital ulcer, simultaneously burn, intractable ulcer, suppurative focus, chapped skin disease, hemorrhoid etc. is all reached ideal curative effect.The world of medicine's blank of special for treating decubital ulcer medicine has for many years been filled up in the appearance of this medicine, is the product of unique special for treating decubital ulcer medicine.It is the development and the extension of motherland's medical science, be further developing of moisture treatment, this medicine is that extracted form natural plant, effective ingredient refine form, thereby reaches the purpose that the patient does not have pain, infection, prevention necrosis progrediens, putrefaction-removing granulation-promoting, impels the skin ulcer face to heal in advance.
Clinical statistics:
A, according to the evolution of decubital ulcer, the light and heavy degree difference can be divided into for three phases:
(1), slight decubital ulcer (also claiming congestion the ruddy phase): the local skin pressurized or be subjected to moist the stimulation after, blood circulation is obstructed, but does not have diabrosis, rubicundity, blackout, blue;
(2), moderate decubital ulcer (also claiming the inflammatory infiltration phase): if red and swollen portion continues pressurized, blood circulation can not get improving, and the pressure surface color of the leather transfers to purplish red, and skin vesicle occurs because of the edema attenuation, and this moment is ulceration easily, manifests moist ruddy wound surface;
(3), severe bedsore (also claiming the ulcer phase): venous backflow is subjected to serious hindrance, and local congestion hyperamization bolt forms, tissue ischemia anoxia, the infection of the lighter shallow layer tissue, pus outflow, ulcer; Weight person's slough blackout, purulent secretion increases, and frowziness infects reaching the deep expansion towards periphery, can reach skeleton, even cause septicemia.
B, decubital ulcer pathogenic factor: the overwhelming majority is because the patient that cardiovascular and cerebrovascular vessel sequela and bone injury long-term bed do not rise, and seldom a part is Long-term Indoor work, the staff who grows based on seat, time.
C, case are selected: accepted decubital ulcer patient 1220 examples altogether for medical treatment since 76 years, male 951 people account for 78%, and women 269 people account for 22%; Slight patients with bedsore 140 people account for 11%, and moderate patients with bedsore 880 people account for 72%, and severe bedsore patient 200 people account for 16%.
D, Therapeutic Method:
Slight decubital ulcer: coat medicine of the present invention in the affected part, three to five times on the one, add slight massaging in case of necessity;
The moderate decubital ulcer: at first clean the skin ulcer face, medicine of the present invention evenly is applied to (thickness 1-2mm) on the aseptic dressing, cover the skin ulcer face, wrapping is fixing, once a day;
Severe bedsore: medicine of the present invention is made oily husky bar, send into vomica with probe, the reuse aseptic dressing applies fixing getting final product, and change dressings once every day.
E, therapeutic outcome: cure rate 96%, effective percentage 98%, no pain, infection in whole therapeutic process, removing the necrotic tissue and promoting granulation, wound healing is rapid.
F, model case:
Slight decubital ulcer: Lee, the man, 56 years old, apoplexy sequela, long-term bed, the long-term pressurized of buttocks, skin is darkviolet, and dry nothing is oozed out.Treatment: local coating band bed sore ointment of the present invention a little, slightly massaged every day three times 5-10 minute.Therapeutic effect: after 5 days, decubital ulcer returns to one's perfect health, and recovers the normal skin color.
The moderate decubital ulcer: grandson, the woman, 62 years old, Fracture of femur patient, the sky surplus in the of 30 of lying in bed, RG skin ulceration, rubescent on every side, area reaches 5 * 5cm, oozes out weak yellow liquid on a small quantity.Treatment: after the sterilization of skin ulcer face, local directly coating band bed sore ointment 2-3mm of the present invention, the dressing wrapping, once-a-day.Therapeutic outcome: the skin ulcer face does not have the cicatrix healing after two weeks, and it is normal that skin recovers.
Severe bedsore: high certain, the man, 70 years old, the hemiplegic patient, long-term bed, the bilateral sciatic bedsore, through topical therapeutic, the state of an illness increases the weight of, the bilateral about 7 * 8cm of face that festers,, the dark 5mm of vomica, stream yellow-white pus, pain unbearably.Treatment: band bed sore ointment of the present invention is made oily yarn emery stick, put into vomica, the part of festering oil yarn covers, the dressing wrapping, and change dressings 1-2 every day.Therapeutic outcome: through 4 all left and right sides times, the skin ulcer face disappears, skin healing.
The specific embodiment:
Embodiment 1: a kind of band bed sore ointment forms by the following bulk drugs that with the weight portion is unit is refining: 5 parts in the Radix Rehmanniae, 5 parts of Radix Achyranthis Bidentataes, 10 parts of Radix Angelicae Sinensis, 5 parts of Rhizoma Corydalis, 5 parts of Olibanums, 2 parts on Flos Carthami, 5 parts of Radix Scutellariaes, 5 parts of Cortex Phellodendris, 5 parts of Rhizoma Atractylodis, 1 part of Sanguis Draxonis, 0.5 part of Borneolum Syntheticum, 1 part of Radix Notoginseng, 0.1 part of Calomelas, 100 parts in Cera Flava, 800 parts in Oleum Sesami.
The production method of band bed sore ointment recited above, its concrete steps are as follows:
A. select materials: select first-class medicine according to the crude drug weight proportion;
B. purify: according to the conventional medicine processing method, various raw materials are cleaned, purify, concoct, standby then;
C. the Oleum Sesami of described weight portion is put into container, under 210～240 ℃ temperature conditions, heated 20～30 minutes;
D. the Radix Rehmanniae, Radix Achyranthis Bidentatae, Radix Angelicae Sinensis, Rhizoma Corydalis, Olibanum, Flos Carthami, Radix Scutellariae, Cortex Phellodendri, Rhizoma Atractylodis are added in the container, heating 20～30 minutes is continued in the back that stirs, and temperature is controlled at 210～240 ℃, roguing, filters, leaves standstill;
E. treat to add when the filtrate temperature is reduced to 120～180 ℃ Cera Flava and Radix Notoginseng powder, the roguing of mixing and stirring after-filtration;
Add Borneolum Syntheticum, Sanguis Draxonis and Calomelas when treating F. that temperature of liquid is reduced to 70～90 ℃, mixing and stirring is after dissolving, airtight, leave standstill, cool off;
G. treat that temperature drops to fill behind the room temperature.
Embodiment 2: the present embodiment production method is with embodiment 1, and something in common does not repeat, and difference is: a kind of band bed sore ointment, form by the following bulk drugs that with the weight portion is unit is refining: 15 parts in the Radix Rehmanniae, 15 parts of Radix Achyranthis Bidentataes, 20 parts of Radix Angelicae Sinensis, 20 parts of Rhizoma Corydalis, 15 parts of Olibanums, 10 parts on Flos Carthami, 20 parts of Radix Scutellariaes, 20 parts of Cortex Phellodendris, 20 parts of Rhizoma Atractylodis, 5 parts of Sanguis Draxonises, 5 parts of Borneolum Syntheticums, 15 parts of Radix Notoginseng, 2 parts of Calomelass, 150 parts in Cera Flava, 1500 parts in Oleum Sesami.
Embodiment 3: the present embodiment production method is with embodiment 1, and something in common does not repeat, and difference is: a kind of band bed sore ointment, form by the following bulk drugs that with the weight portion is unit is refining: 10 parts in the Radix Rehmanniae, 10 parts of Radix Achyranthis Bidentataes, 12 parts of Radix Angelicae Sinensis, 9 parts of Rhizoma Corydalis, 9 parts of Olibanums, 5 parts on Flos Carthami, 9 parts of Radix Scutellariaes, 9 parts of Cortex Phellodendris, 9 parts of Rhizoma Atractylodis, 2 parts of Sanguis Draxonises, 1 part of Borneolum Syntheticum, 5 parts of Radix Notoginseng, 0.5 part of Calomelas, 120 parts in Cera Flava, 1000 parts in Oleum Sesami.
Embodiment 4: the present embodiment production method is with embodiment 1, and something in common does not repeat, and difference is: a kind of band bed sore ointment, form by the following bulk drugs that with the weight portion is unit is refining: 5 parts in the Radix Rehmanniae, 15 parts of Radix Achyranthis Bidentataes, 15 parts of Radix Angelicae Sinensis, 10 parts of Rhizoma Corydalis, 15 parts of Olibanums, 8 parts on Flos Carthami, 10 parts of Radix Scutellariaes, 15 parts of Cortex Phellodendris, 10 parts of Rhizoma Atractylodis, 3 parts of Sanguis Draxonises, 2 parts of Borneolum Syntheticums, 10 parts of Radix Notoginseng, 0.5 part of Calomelas, 130 parts in Cera Flava, 1200 parts in Oleum Sesami.
Embodiment 5: the present embodiment production method is with embodiment 1, and something in common does not repeat, and difference is: a kind of band bed sore ointment, form by the following bulk drugs that with the weight portion is unit is refining: 15 parts in the Radix Rehmanniae, 5 parts of Radix Achyranthis Bidentataes, 20 parts of Radix Angelicae Sinensis, 5 parts of Rhizoma Corydalis, 15 parts of Olibanums, 5 parts on Flos Carthami, 15 parts of Radix Scutellariaes, 20 parts of Cortex Phellodendris, 8 parts of Rhizoma Atractylodis, 4 parts of Sanguis Draxonises, 25 parts of Borneolum Syntheticums, 7 parts of Radix Notoginseng, 1 part of Calomelas, 130 parts in Cera Flava, 1300 parts in Oleum Sesami.
Embodiment 6: the present embodiment production method is with embodiment 1, and something in common does not repeat, and difference is: a kind of band bed sore ointment, form by the following bulk drugs that with the weight portion is unit is refining: 6 parts in the Radix Rehmanniae, 11 parts of Radix Achyranthis Bidentataes, 12 parts of Radix Angelicae Sinensis, 17 parts of Rhizoma Corydalis, 8 parts of Olibanums, 6 parts on Flos Carthami, 15 parts of Radix Scutellariaes, 10 parts of Cortex Phellodendris, 10 parts of Rhizoma Atractylodis, 3 parts of Sanguis Draxonises, 0.8 part of Borneolum Syntheticum, 10 parts of Radix Notoginseng, 1 part of Calomelas, 140 parts in Cera Flava, 900 parts in Oleum Sesami.
Claims (3)
1. a band bed sore ointment is characterized in that: form by the following bulk drugs that with the weight portion is unit is refining: 5～15 parts in the Radix Rehmanniae, 5～15 parts of Radix Achyranthis Bidentataes, 10～20 parts of Radix Angelicae Sinensis, 5～20 parts of Rhizoma Corydalis, 5～15 parts of Olibanums, 2～10 parts on Flos Carthami, 5～20 parts of Radix Scutellariaes, 5～20 parts of Cortex Phellodendris, 5～20 parts of Rhizoma Atractylodis, 1～5 part of Sanguis Draxonis, 0.5～5 part of Borneolum Syntheticum, 1～15 part of Radix Notoginseng, 0.1～2 part of Calomelas, 100～150 parts in Cera Flava, 800～1500 parts in Oleum Sesami.
2. band bed sore ointment according to claim 1 is characterized in that: formed by the following natural material YAOJING system that with the weight portion is unit: 10 parts in the Radix Rehmanniae, 10 parts of Radix Achyranthis Bidentataes, 12 parts of Radix Angelicae Sinensis, 9 parts of Rhizoma Corydalis, 9 parts of Olibanums, 5 parts on Flos Carthami, 9 parts of Radix Scutellariaes, 9 parts of Cortex Phellodendris, 9 parts of Rhizoma Atractylodis, 2 parts of Sanguis Draxonises, 1 part of Borneolum Syntheticum, 5 parts of Radix Notoginseng, 0.5 part of Calomelas, 120 parts in Cera Flava, 1000 parts in Oleum Sesami.
3. the production method of claim 1 or 2 described band bed sore ointments, its concrete steps are as follows:
A. select materials: select first-class medicine according to the crude drug weight proportion;
B. purify: according to the conventional medicine processing method, various raw materials are cleaned, purify, concoct, standby then;
C. the Oleum Sesami of described weight portion is put into container, under 210～240 ℃ temperature conditions, heated 20～30 minutes;
D. the Radix Rehmanniae, Radix Achyranthis Bidentatae, Radix Angelicae Sinensis, Rhizoma Corydalis, Olibanum, Flos Carthami, Radix Scutellariae, Cortex Phellodendri, Rhizoma Atractylodis are added in the container, heating 20～30 minutes is continued in the back that stirs, and temperature is controlled at 210～240 ℃, roguing, filters, leaves standstill;
E. treat to add when the filtrate temperature is reduced to 120～180 ℃ Cera Flava and Radix Notoginseng powder, the roguing of mixing and stirring after-filtration;
Add Borneolum Syntheticum, Sanguis Draxonis and Calomelas when treating F. that temperature of liquid is reduced to 70～90 ℃, mixing and stirring is after dissolving, airtight, leave standstill, cool off;
G. treat that temperature drops to fill behind the room temperature.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101413345A CN101352504B (en) | 2008-09-11 | 2008-09-11 | Bedsore plaster and method for producing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101413345A CN101352504B (en) | 2008-09-11 | 2008-09-11 | Bedsore plaster and method for producing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101352504A CN101352504A (en) | 2009-01-28 |
| CN101352504B true CN101352504B (en) | 2011-02-16 |
Family
ID=40305676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008101413345A Expired - Fee Related CN101352504B (en) | 2008-09-11 | 2008-09-11 | Bedsore plaster and method for producing the same |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101352504B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102293880B (en) * | 2011-08-26 | 2013-04-24 | 天津尖峰弗兰德医药科技发展有限公司 | External Chinese herbal preparation for treating bedsore and preparation method thereof |
| CN103566088B (en) * | 2013-10-31 | 2016-01-06 | 刘增慧 | A kind of clinical care is used for the treatment of the preparation method of the medicament of decubital ulcer |
| CN110013509A (en) * | 2018-01-09 | 2019-07-16 | 马怀斌 | Innovate burn cream and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1073100A (en) * | 1992-09-30 | 1993-06-16 | 张化文 | Multifunction specific ointment |
| CN1723931A (en) * | 2005-06-14 | 2006-01-25 | 马怀斌 | Cure-all ointment for treating burns and scald |
| CN100341538C (en) * | 2003-07-10 | 2007-10-10 | 姜延德 | Medication for curing scald or burn |
-
2008
- 2008-09-11 CN CN2008101413345A patent/CN101352504B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1073100A (en) * | 1992-09-30 | 1993-06-16 | 张化文 | Multifunction specific ointment |
| CN100341538C (en) * | 2003-07-10 | 2007-10-10 | 姜延德 | Medication for curing scald or burn |
| CN1723931A (en) * | 2005-06-14 | 2006-01-25 | 马怀斌 | Cure-all ointment for treating burns and scald |
Non-Patent Citations (2)
| Title |
|---|
| 冯华德，等.中医外治法治疗褥疮近况.《中医药信息》.1993,(第6期),19-20. |
| 冯华德等.中医外治法治疗褥疮近况.《中医药信息》.1993,(第6期),19-20. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101352504A (en) | 2009-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103007124B (en) | Chinese medicine preparation for treating gynecologic inflammation | |
| CN104225138A (en) | Traditional Chinese medicine for treating bedsore through oral administration and external washing and preparation method of traditional Chinese medicine | |
| CN100333763C (en) | Preparation method of bed sore flesh engendering ointment | |
| CN102512616B (en) | Chinese medicinal anti-acne composition | |
| CN101352504B (en) | Bedsore plaster and method for producing the same | |
| CN103948774A (en) | Traditional Chinese medicine solution for internal fistula care and preparation method thereof | |
| CN103316192A (en) | Traditional Chinese medicine foot-bathing liquid for treating lumbocrural pain and preparation method thereof | |
| CN101164604B (en) | Traditional Chinese medicine for treating arthrosis and preparing method thereof | |
| CN102764393A (en) | Medicine for treating ankylosing spondylitis | |
| CN109674945A (en) | The Chinese medicine composition and preparation method thereof of ulcer is cured in a kind of myogenic hemostasia and detumescence analgesic | |
| CN102302576B (en) | Chinese medicinal composition for treating ischemic necrosis of femoral head | |
| CN101244213B (en) | Externally used Chinese medicinal herb for treating decubitus | |
| CN104055922A (en) | Traditional Chinese medicinal preparation for treating pressure sores and preparation method thereof | |
| CN105770347A (en) | Pure traditional Chinese medicinal oil for burns, scalds, wounds and ulcers and preparation method of pure traditional Chinese medicinal oil | |
| CN106421392A (en) | Traditional Chinese medicinal gel for treating bedsore and preparation method of traditional Chinese medicinal gel | |
| CN106309813A (en) | Traditional Chinese medicinal ointment for treating bedsores | |
| CN104887970A (en) | Acupuncture and moxibustion physiotherapy ointment for external use | |
| CN105617198A (en) | Method for preparing medicinal liquor for treating wind-cold low back pain | |
| CN101032600A (en) | Ultramicro medicine powder for curing burn and scald and its preparation | |
| CN104083719A (en) | Traditional Chinese medicine for treating hyperplasia of mammary glands and preparation method of traditional Chinese medicine | |
| CN102824495B (en) | Traditional Chinese medicine ointment for treating bedsore in clinical care and preparation method of ointment | |
| CN1075726C (en) | Oral liquid for treatment of heart disease and its prepn. method | |
| CN102188566B (en) | Medicinal liquor for treating ischialgia | |
| CN105381366A (en) | Traditional Chinese medicine composition for treating bedsores and preparing method thereof | |
| CN105194517A (en) | Traditional Chinese medicine for treating kidney-marrow deficiency type tinnitus cerebri |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110216 Termination date: 20140911 |
|
| EXPY | Termination of patent right or utility model |